By Martin S. Kohn, MD, MS, FACEP, FACPE, Chief Medical Scientist, Sentrian
Fully one-third of the money spent on healthcare in the United States – roughly $900 billion dollars a year – is wasted on things of no value.[i] That recognition is driving the most significant trend among healthcare providers today: A concerted effort to simultaneously improve quality and control cost. That dual goal marks a distinct change from past efforts, which focused only on controlling utilization and not improving clinical outcomes.
To get to the goal, providers must first focus on the population of patients that accounts for approximately 70 percent of the healthcare spend in the US – those with established chronic disease. Chronic disease patients, such as those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or diabetes, experience frequent hospitalizations and other expensive acute care interventions. Thus, targeting established chronic disease is an important effort in transforming healthcare, improving outcomes and curbing expenditures. Although the ideal would be a health system that can prevent patients from developing chronic diseases, the burden is chronic diseases dominates the current scene.
Please log in or register below to read the full article.